Compare HRMY & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRMY | INOD |
|---|---|---|
| Founded | 2017 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2020 | 1993 |
| Metric | HRMY | INOD |
|---|---|---|
| Price | $35.24 | $56.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $50.56 | ★ $91.67 |
| AVG Volume (30 Days) | 934.4K | ★ 1.5M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 50.44 | ★ 62.46 |
| EPS | ★ 3.17 | 1.01 |
| Revenue | ★ $825,944,000.00 | $238,467,000.00 |
| Revenue This Year | $20.68 | $48.07 |
| Revenue Next Year | $15.93 | $24.55 |
| P/E Ratio | ★ $11.14 | $56.93 |
| Revenue Growth | 21.13 | ★ 73.57 |
| 52 Week Low | $25.52 | $26.41 |
| 52 Week High | $40.93 | $93.85 |
| Indicator | HRMY | INOD |
|---|---|---|
| Relative Strength Index (RSI) | 71.09 | 41.54 |
| Support Level | $32.77 | $49.71 |
| Resistance Level | $36.20 | $57.30 |
| Average True Range (ATR) | 1.11 | 4.21 |
| MACD | 0.17 | 0.03 |
| Stochastic Oscillator | 81.04 | 32.34 |
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.